Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

October 31, 2007

Conditions
DiarrheaClostridium Infections
Interventions
DIETARY_SUPPLEMENT

Lactobacillus acidophilus CL1285 and Lactobacillus casei

One bottle daily 2 hours before or after antibiotic administration and for 5 days following the termination of antibiotic regimen.

DIETARY_SUPPLEMENT

placebo

One bottle daily 2 hours before or after antibiotic administration and for 5 days following the termination of antibiotic regimen.

Trial Locations (8)

L8L-2X2

Hamilton General Hospital, Hamilton

K7L 2V7

Kingston General Hospital, Kingston

M2K 1E1

North York General Hospital, Toronto

G7H5H6

Hotel Dieu de Chicoutimi, Chicoutimi

H3T 1M5

St-Mary Hospital Center, Montreal

G1V 4G5

Laval Hospital, Québec

J7Z 5T3

Hotel-Dieu de St-Jerome, Saint-Jérôme

G8Z 3R9

Centre Hospitalier Régional de Trois-Rivières, Trois-Rivières

Sponsors
All Listed Sponsors
collaborator

JSS Medical Research Inc.

INDUSTRY

lead

Bio-K Plus International Inc.

INDUSTRY